Ignite Creation Date:
2024-05-06 @ 3:48 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04767373
Status:
COMPLETED
Last Update Posted:
2023-07-17
First Post:
2021-02-22
Brief Title:
Efficacy and Safety of Clesrovimab MK-1654 in Infants MK-1654-004
Sponsor:
Organization:
Merck Sharp Dohme LLC